专题:Mechanisms of Drug-Induced Hepatotoxicity

This cluster of papers focuses on the mechanisms, risk factors, biomarkers, and management of drug-induced hepatotoxicity, with a specific emphasis on acetaminophen-induced liver injury. It covers topics such as oxidative stress, mitochondrial dysfunction, HLA genotype associations, idiosyncratic reactions, and the role of liver transplantation in severe cases.
最新文献
Alimentary protein deficiency aggravates mitochondrial dysfunction in animals with acetaminophen-induced kidney injury

article Full Text OpenAlex

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation

article Full Text OpenAlex

Correspondence regarding the article by Hüser et al. on “Critical care management of the patient with pharmaceutical poisoning”

article Full Text OpenAlex

Human periportal liver assembloids

article Full Text OpenAlex

Quantitative Proteomics Reveals Significant Downregulation of Glutathione Metabolism in Sepsis-Induced Liver Injury

article Full Text OpenAlex

Tuning Lipophilicity to Develop an MMP-Independent Fluorescent Probe for Visualizing Mitochondrial Peroxynitrite in Drug-Induced Liver Injury

article Full Text OpenAlex

Acute liver injury associated with tirzepatide: an unexpected adverse event warranting clinical attention

article Full Text OpenAlex

Aspirin for Primary Prevention in Metabolic Dysfunction‐Associated Steatotic Liver Disease

article Full Text OpenAlex

First Report of Lipoprotein X Formation in Methimazole-Induced Cholestatic Jaundice with Agranulocytosis

article Full Text OpenAlex

Sinapic acid attenuates colistin-driven nephrotoxicity by targeting the miRNA-21/SIRT1/NF-κB pathway and facilitating tubular repair and inflammation in a rat model

article Full Text OpenAlex

近5年高被引文献
Global burden of liver disease: 2023 update

review Full Text OpenAlex 1681 FWCI592.77833163

Nirmatrelvir Plus Ritonavir: First Approval

review Full Text OpenAlex 282 FWCI34.80053913

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

article Full Text OpenAlex 274 FWCI50.50861632

Drug-Induced Acute Kidney Injury

article Full Text OpenAlex 262 FWCI49.00762756

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

article Full Text OpenAlex 253 FWCI75.22107578

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

review Full Text OpenAlex 251 FWCI58.0051129

Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity

review Full Text OpenAlex 219 FWCI25.72145402

International Journal of Pharmacy and Pharmaceutical Science

paratext Full Text OpenAlex 206 FWCI0

Acute-on-Chronic Liver Failure Clinical Guidelines

review Full Text OpenAlex 205 FWCI37.55287459

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

article Full Text OpenAlex 190 FWCI42.39731143